NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE37710 Query DataSets for GSE37710
Status Public on May 04, 2012
Title MiR-27a-3p in peripheral blood mononuclear cells as a potential marker for pancreatic cancer screening
Organism Homo sapiens
Experiment type Non-coding RNA profiling by high throughput sequencing
Summary Background & Aims: MicroRNAs have been shown to offer great potential in the diagnosis of cancer. We aimed to identify microRNAs in peripheral blood mononuclear cells (PBMCs) for diagnosing pancreatic cancer (PC). Methods: PBMCs microRNA expression was investigated in three independent cohorts including 352 participants (healthy, benign pancreatic/peripancreatic diseases (BPD), and PC). First, we used sequencing technology to identify differentially expressed microRNAs in 60 PBMCs samples for diagnosing PC. Quantitative reverse-transcriptase polymerase chain reaction assay was then applied to evaluate the expression of selected microRNAs. A logistic regression model was constructed using an independent cohort. Area under the receiver operating characteristic curve (AUC) was used to evaluate diagnostic accuracy. Results: We found that PBMCs miR-27a-3p could efficiently discriminate PC from BPD (AUC=0.840; 95% CI, 0.787 to 0.885; sensitivity=82.2%, specificity=76.7%). A panel composed of PBMCs miR-27a-3p and serum CA19-9 provided a high diagnostic accuracy in differentiating PC from BPD in the clinical setting (AUC=0.886; 95% CI, 0.837 to 0.923; sensitivity=85.3%, specificity=81.6%). The satisfactory diagnostic performance of the panel persisted regardless of disease status (AUCs for tumour-node-metastasis stagesⅠ,Ⅱ, and Ⅲ were 0.881, 0.884, and 0.893, respectively). Conclusion: PBMCs miR-27a-3p could be a potential marker for PC screening. A panel composed of PBMCs miR-27a-3p and serum CA19-9 has considerable clinical value in diagnosing early-stage PC. Therefore, patients who would have otherwise missed the curative treatment window can benefit from optimal therapy.
 
Overall design Examination of different MicroRNA profiles in 3 types of PBMCs samples
 
Contributor(s) Wang W, Liu L, Li G, Chen Y, Li C, Jin D, Wang X
Citation(s) 23430754
Submission date May 02, 2012
Last update date May 15, 2019
Contact name xiaolin wang
E-mail(s) wwsdj2002@163.com
Organization name Zhongshan Hospital, Fudan University
Street address 180 Feng Lin Rd
City Shanghai
ZIP/Postal code 200032
Country China
 
Platforms (1)
GPL11154 Illumina HiSeq 2000 (Homo sapiens)
Samples (3)
GSM925875 PDAC smallRNAseq
GSM925876 BPD smallRNAseq
GSM925877 Healthy smallRNAseq
Relations
SRA SRP012608
BioProject PRJNA163233

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE37710_BPD-Healthy.express.txt.gz 15.5 Kb (ftp)(http) TXT
GSE37710_BPD-PDAC.express.txt.gz 14.9 Kb (ftp)(http) TXT
GSE37710_PDAC-Healthy.express.txt.gz 15.5 Kb (ftp)(http) TXT
SRA Run SelectorHelp
Processed data are available on Series record
Raw data are available in SRA

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap